Combined effects of antineoplastic agents and anti-lymphoma allograft reactions.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002330:Carmustine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D005260:Female; D006648:Histocompatibility; D006789:Host vs Graft Reaction; D007939:Leukemia L1210 / Q000188:drug therapy / Q000276:immunology; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000276:immunology; D008223:Lymphoma / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D014184:Transplantation, Homologous; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014750:Vincristine; D003606:Dacarbazine; D003520:Cyclophosphamide; D002330:Carmustine